Jeff Brown is out with a new presentation – The Shocking Truth Behind Soaring Biotech Stocks – for his Near Future Report newsletter. Learn more about Jeff Brown’s #1 FDA guaranteed biotech pick for 2021 in Jeff’s new report The Next King of Biotech.
How You Could Lock in a 1,110% Return on THIS Stock in Just 24 Hours
Table of Contents
- 1 Jeff Brown’s Shocking Truth Behind Soaring Biotech Stocks
- 2 What Is Jeff Brown’s #1 FDA Guaranteed Biotech Pick?
- 3 Jeff Brown’s Next King of Biotech Report
- 4 What Is Jeff Brown’s Near Future Report?
- 5 What’s Included With Your The Near Future Report Subscription?
- 5.1 One-Year Membership to The Near Future Report
- 5.2 New Special Report: The Next King of Biotech: Unlocking the Genetic Therapy Revolution
- 5.3 Bonus Report #1: The New Economy: 5 Stocks that Will Soar in the “Post-Covid” World
- 5.4 Bonus Report #2: Toxic Tech: 5 Tech “Darlings” to Dump Right Now
- 5.5 Bonus Report #3: Project Xi: Two Explosive Stocks Behind the $15 Trillion Tech Revolution
- 5.6 Surprise Bonus Report #4: The #1 Biotech Stock of 2021
- 6 The Near Future Report Subscription Fee
- 7 The Near Future Report Refund Policy
- 8 Final Thoughts
Jeff Brown’s Shocking Truth Behind Soaring Biotech Stocks
1.2 trillion dollars. That’s how much a little-known FDA move has pumped into biotechnology. It’s fueling a growing bull run in the sector. It’s behind 9 of the top 10 best-selling biotechs of the 21st century. All companies that have generated over $100 billion dollars EACH.
And get this… experts predict it could soon unleash another trillion. But not all biotech companies will be on the receiving end of this money. Most are completely locked out.
Discover why in this presentation by Jeff Brown. He picked the top tech stocks of 2016, 2018, 2019, and 2020. Now, Jeff Brown found one company he believes stands to profit most from this next round of wealth. You’ll also get his #1 investment pick for this second round of wealth.
Jeff Brown’s #1 FDA Guaranteed Biotech Pick – Click here for the full story.
— RECOMMENDED —
A Personal Profit of $7,600 PER DAY?!
Dr. Kent Moors, has unveiled his powerhouse algorithmic trading system…
The result was a win streak of 44 triple digit gains… 129 winning trades… and a win rate of 93%.
Kent averaged a personal profit of $7,600 per day.
In fact, over the last 6 weeks, he has nailed down 17 more triple digit wins.
What Is Jeff Brown’s #1 FDA Guaranteed Biotech Pick?
Don’t have to watch the whole presentation? Here’s the main idea in short …
Jeff Brown put together a special report that outlines the opportunity in front of you. It’s called The Next King of Biotech: Unlocking the Genetic Therapy Revolution. It includes his #1 FDA guaranteed biotech pick.
This company has solved the single biggest limitation of genetic therapy. It’s a problem that’s plagued the entire genetic therapy revolution from the start.
Here it is…
For decades, we’ve heard the word “could” associated with genetic therapy. If you “could” simply fix the gene associated with any of these 10,000 known genetic diseases, you “could” cure the disease… for life. But until now, there was no reliable way to do this. That’s because while it’s now relatively easy to IDENTIFY the missing or mutated genes associated with these 10,000 diseases…
It’s quite another thing to FIX that missing or mutated gene.
After all, your genes are hidden deep within the DNA of every one of your cells. And your body is a fortress. Even if you had a drug that could fix a faulty gene, it would do ZERO good if you can’t get it to your cells. It’s a herculean task.
Your skin… your lungs… your kidneys… your liver… your immune system… and so much more… there are multiple layers of protection. All designed to stop anything that looks like a threat from getting to your cells.
The trick now is NOT identifying which genes are broken. And it’s not even that difficult to make the drugs to fix these genes…
The problem now is how do we get that drug through the multiple defenses of your body.
It’s the single biggest limitation stopping the revolution of the next generation of medicines
And that’s why I’m so excited about Jeff’s #1 pick.
Like Jeff Brown mentioned in his presentation, they’ve gotten FDA approval for SIX drugs that fix genetic mutations. An amazing feat.
But more importantly…
During that process they’ve developed, perfected, and filed patents for a new delivery method for these new drugs.
— RECOMMENDED —
WARNING!!!
The clock is ticking on the biggest financial event in 20 years.
And if you want to take advantage, you must position yourself in the early days of 2021.
Jeff Brown’s Next King of Biotech Report
All the details are outlined in The Next King of Biotech: Unlocking the Genetic Therapy Revolution report. Complete with company name, ticker symbol, and full company profile…And full details on this trillion dollar genetic medicine revolution…
As of today, anyone with a standard brokerage account can secure shares in it well below Jeff’s buy up to price.
And you can have this report for free when you subscribe for Jeff Brown’s Near Future Report newsletter.
What Is Jeff Brown’s Near Future Report?
The goal of Jeff Brown’s Near Future Report research service is simple:
To help ordinary people learn how to make profits on breakthrough technologies on the verge of mass adoption. Trends that are far too complex for the mainstream press to understand, much less help you profit from.
Jeff Brown has shown you in his presentation a few of the triple-digit gains his readers could have locked in…
And right now in Jeff Brown’s Near Future Report portfolio of open recommendations… 27 of Jeff’s 29 recommendations have posted gains.
That’s a winning rate north of 92%.
These are not boring, stodgy picks you’ll hear about in the mainstream media. These are the future technologies that will power our world. And generate long-term growth for your retirement portfolio.
— RECOMMENDED —
Want the chance to put $2,500, $5,000, $10,000, or more in your pocket every Thursday?
What’s Included With Your The Near Future Report Subscription?
Here’s Everything You Get:
One-Year Membership to The Near Future Report
Jeff Brown keeps picking #1 technology winners. And with The Near Future Report, you’ll get 12 monthly issues of his flagship report, each with a brand-new recommendation. You’ll also get complimentary 24/7 access to the member’s only website, featuring Jeff’s full model portfolio of tech picks and archives of past issues and special reports.
New Special Report: The Next King of Biotech: Unlocking the Genetic Therapy Revolution
Important: The moment you subscribe to The Near Future Report, you’ll receive an email with a link to download this report. It contains the name and ticker symbol of “The Next King of Biotech.”
Bonus Report #1: The New Economy: 5 Stocks that Will Soar in the “Post-Covid” World
Over the past 24 months, Jeff Brown has shown readers gains as high as 181%, 290%, 339%, 34%, 106%, 87%, and 108% by capitalizing on changes in 5G, artificial intelligence, cloud computing, cryptocurrency, future transportation, and yes, precision medicine. The 5 companies inside this report have the potential to do that and more. You’ll get their names, ticker symbols, company profiles,and full analysis of why they are perfectly positioned to deliver maximum returns to investors as Covid-19 continues to accelerate technology development.
Bonus Report #2: Toxic Tech: 5 Tech “Darlings” to Dump Right Now
We’re at a critical juncture in history. The technology market is “splintering.” New upstarts are driving the technology that will be used for the next 50 years. While some Silicon Valley “old guards” are trying to profit from their reputations as their technology falls by the wayside. Wall Street loves these 5 Tech “darlings,” but in this report, Jeff Brown reveals why you must purge them from your portfolio before they ruin your retirement.
Bonus Report #3: Project Xi: Two Explosive Stocks Behind the $15 Trillion Tech Revolution
Covid made it clear. Manufacturing needs to return to America. We can no longer rely on China to supply essential goods like the electronics used by our military… the machinery used to run our factories… and the medicine to keep us alive. In this report, Jeff Brown reveals his two top picks for this next generation of “made in the USA” companies.
Surprise Bonus Report #4: The #1 Biotech Stock of 2021
Because of the rapid developments in biotech, Jeff’s recommending another explosive biotech stock that could top even his #1 pick!
— RECOMMENDED —
Millionaire’s Big Prediction From Living Room Couch
Teeka Tiwari – America’s No. 1 Investor – just made an outrageous prediction.
Recorded live from his living room couch…
He blasts Congress, reveals nasty truths about America…
And reveals one technology set to radically change our nation.
Already, 400,000-plus viewers have checked it out.
WARNING: This video may make you furious.
The Near Future Report Subscription Fee
You can have 1 year of The Near Future Report for $49. (That’s less than $1 per week!)
The Near Future Report Refund Policy
Your membership is backed by Jeff Brown’s total satisfaction guarantee.
If your membership isn’t everything you expected, simply contact Jeff’s customer service team at 888-493-3156 in the first 60 days and they’ll return 100% of your membership fee, no questions asked.
— RECOMMENDED —
Viral Tech Genius Makes Next Big Prediction
Jeff Brown just got off the Shubert Theater stage – where he shared his #1 tech stock for 2021…
And revealed the details behind three valuable new technologies Jeff is certain 99% of the public have never heard of.
Click Here to Watch the Presentation Now
Final Thoughts
We’ve entered a new era of medicine. That new cures for genetic diseases are hitting the market at an unprecedented pace and similar biotechnology stocks have soared 5,575%… 10,461%… and even an extraordinary 30,687%.
But it will get even better…
Because while advances in technology are making these breakthroughs finally possible, lucrative FDA incentives have made creating these cures extremely profitable.
Biotech companies have pocketed trillions of dollars thanks to them. They are behind 9 of the top 10 best-selling drugs of the 21st century… drugs that have sold over $100 billion EACH. And experts predict these FDA incentives will be worth another $1.2 trillion over the next few years.
In short, the genetic therapy revolution is quickly accelerating. And the biggest winner could be the company in The Next King of Biotech: Unlocking the Genetic Therapy Revolution.